Skip to main content
Elsevier - PMC Mpox Collection logoLink to Elsevier - PMC Mpox Collection
. 2022 Sep 26;21(1):A17–A18. doi: 10.1016/j.cgh.2022.09.024

Esophageal Monkeypox lesion

Sharmistha Mishra 1,2, Rishad Khan 3, Adriana Krizova 4, Samir C Grover 2,3
PMCID: PMC9534271  PMID: 36174941

A 30-year-old cis-man living with well-controlled HIV infection presented with a 6-day history of perianal and tongue lesions and 2 days of fever, sweats, and odynophagia manifested as retrosternal chest pain when consuming fluids. His past medical history included HIV, treated with abacavir-dolutegravir-lamivudine and darunavir-cobicistat, with recent CD4 count of 192 and an undetectable viral load, and previously treated Mycobacterium avium complex disease with lymph node involvement. His other medications include trimethoprim-sulfamethoxazole, azithromycin, moxifloxacin, and ethambutol. There was a history of receptive oral intercourse without condoms in the prior 28 days. He had been taking nonsteroidal anti-inflammatory drugs for the perianal pain. Esophagogastroduodenoscopy revealed an 8-mm shallow ulcer in the midesophagus located at 29 cm from the incisors (Figure A). Blood, cutaneous upper thigh lesions (Figure B), and esophageal lesions tested positive for monkeypox virus (MPVX) by polymerase chain reaction. Pathology from an esophageal lesion biopsy showed squamous mucosa with lymphocytic inflammation (Figure C). Other findings that have been reported in esophageal MPVX from animal models include epithelial cell and fibroblast proliferation, multinucleated syncytial cells, and necrotizing lesions. MPVX antigen has also been demonstrated by immunohistochemistry in Cynomolgus monkeys among epithelial cells, macrophages, and fibroblasts from sites with morphologic involvement.

graphic file with name gr1_lrg.jpg

The patient was initiated on tecovirimat. His odynophagia began to improve 2 days after initiating treatment. At follow-up 2 weeks from esophagogastroduodenoscopy, his perianal and tongue lesions had resolved. Although rates of esophageal involvement among patients with MPVX infection are unclear because of lack of endoscopic investigations in most patients, dysphagia and odynophagia are reported in up to 70% of patients. These symptoms may be caused by oral ulceration, but should also signal the possibility of upper gastrointestinal involvement and endoscopic evaluation.

Footnotes

Conflicts of interest These authors disclose the following: Rishad Khan has received research grants from AbbVie (2018) and Ferring Pharmaceuticals (2019) and research funding from Pendopharm (2019). Samir C. Grover has received research grants and personal fees from AbbVie and Ferring Pharmaceuticals, personal fees from Takeda, education grants from Janssen, and has equity in Volo Healthcare. The remaining authors disclose no conflicts.


Articles from Clinical Gastroenterology and Hepatology are provided here courtesy of Elsevier

RESOURCES